Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201

Jordan R. Hansford, Gauthier Bouche, Vijay Ramaswamy, Nada Jabado, Adriana Fonseca, Sam Moloney, Nicholas G. Gottardo, Giles W. Robinson, Amar Gajjar, Christopher L. Tinkle, Paul G. Fisher, Nicholas Foreman, David M. Ashley, David S. Ziegler, David D. Eisenstat, Maura Massimino, Olaf Witt, Ute Bartels, Stefan Rutkowski, Darren HargraveMaryam Fouladi, Stefan M. Pfister, Eric Bouffet

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Our international team highlights issues with efficacy reports in several studies on DMG with the new drug ONC201.

Original languageEnglish
Pages (from-to)4126-4129
Number of pages4
JournalJournal of Clinical Oncology
Volume42
Issue number35
DOIs
Publication statusPublished or Issued - 10 Dec 2024
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this